Atherosclerotic Plaque Pathways Targeted by GLP-1RAs The use of liraglutide and semaglutide, as shown in the LEADER and SUSTAIN-6 trials, reduces the occurrence of MACEs in high-risk CVD patients with diabetes
The proposed MCL would streamline discovery across cases currently scattered among eight different judges while maintaining the focus on the unique aspects of optic nerve damage rather than digestive system complications
Yami brings you the most popular Korean glutathione supplements and skincare directly to your doorstep
In a recent study published in The Lancet Diabetes Endocrinology , researchers evaluate the effects of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes
Designed to support the "Brain-Body Connection," ACE G2 helps you stay sharp, focused, and motivated throughout your most demanding tasks
10.1038/s41598-024-56818-4 Sci Rep